NPO for at least 8 hours, preoperative antibiotic prophylaxis, urine culture to ensure sterility, detailed surgical consent, anesthesia assessment, bowel preparation if necessary, and perioperative DVT prophylaxis.
Strict bed rest for the first 24 hours, maintenance of urethral catheter for 14-21 days, oral hygiene maintenance, pain management, early ambulation after 24 hours, monitoring for hematoma or graft site infection, and outpatient follow-up for retrograde urethrography before catheter removal.
Comprehensive Clinical Guide: Buccal Mucosal Graft Urethroplasty (BMGU)
1. Introduction and Overview
Urethroplasty remains the gold standard for the definitive management of urethral stricture disease. Among the various reconstructive techniques, Buccal Mucosal Graft Urethroplasty (BMGU) has emerged as the superior method for managing long, complex, or recurrent anterior urethral strictures.
The buccal mucosa—the lining of the inner cheek—is the ideal donor tissue for urethral reconstruction due to its unique histological properties: it is non-keratinized, highly vascularized, resilient to infection, and possesses a thin, elastic epithelial layer that integrates seamlessly with the urethral environment. This guide provides an exhaustive clinical overview of BMGU, intended for medical professionals and clinical stakeholders.
2. Technical Specifications and Mechanisms
The Biology of the Buccal Graft
The success of BMGU lies in the "take" of the graft. Unlike skin grafts, which may shrink or undergo keratinization when exposed to urine, buccal mucosa remains stable.
| Feature | Clinical Advantage |
|---|---|
| Non-keratinized epithelium | Resists desquamation and stone formation. |
| High vascularity | Promotes rapid inosculation and imbibition (graft survival). |
| Thin lamina propria | Allows for easy suturing and contouring. |
| Elasticity | Accommodates the dynamic nature of the urethra. |
Surgical Mechanisms
The procedure functions on the principle of substitution urethroplasty. When the urethral lumen is narrowed by spongiofibrosis (scar tissue), the surgeon excises or incises the stricture and patches the defect with the buccal graft. This effectively increases the urethral caliber, restoring normal micturition and uroflowmetry parameters.
3. Clinical Indications and Usage
BMGU is indicated for patients with complex urethral stricture disease where simple dilation or internal urethrotomy has failed or is deemed inappropriate.
Primary Indications:
- Recurrent Strictures: Patients who have failed at least one endoscopic procedure (DVIU).
- Long-segment Strictures: Strictures exceeding 2cm in length.
- Lichen Sclerosus (BXO): The preferred treatment for BXO-related strictures, as the graft is resistant to the inflammatory process.
- Hypospadias Failures: Used in salvage procedures for failed hypospadias repairs.
- Traumatic Strictures: Straddle injuries resulting in significant spongiofibrosis.
Pre-Operative Preparation
- Patient Optimization: Cessation of smoking (4 weeks prior) to enhance graft take.
- Imaging: Retrograde Urethrogram (RUG) and Voiding Cystourethrogram (VCUG) to map the exact length and location of the stricture.
- Endoscopy: Flexible or rigid cystoscopy to assess the quality of the urethral mucosa.
- Informed Consent: Detailed discussion regarding donor site morbidity (mouth) and potential urinary complications.
- Prophylaxis: Broad-spectrum antibiotics administered intravenously at the induction of anesthesia.
4. The Procedure: Step-by-Step
Phase I: Harvesting the Graft
The surgeon harvests the tissue from the inner cheek, avoiding the Stensen’s duct (parotid duct).
* Marking: The area is marked, typically 2cm x 5cm, depending on the required length.
* Harvesting: A submucosal injection of saline/epinephrine is used to hydro-dissect the tissue, facilitating a clean harvest while minimizing bleeding.
* Closure: The donor site is closed with absorbable sutures to prevent hematoma and minimize pain.
Phase II: Urethral Reconstruction
- Exposure: A perineal incision is made to expose the bulbous urethra.
- Stricturotomy: The strictured segment is opened longitudinally (ventral or dorsal approach).
- Graft Inlay/Onlay: The buccal graft is defatted and sutured onto the urethral edges using fine, absorbable monofilament (e.g., 5-0 PDS).
- Quilting: The graft is "quilted" to the underlying tunica albuginea to ensure absolute contact and prevent hematoma formation beneath the graft.
5. Post-Operative Recovery Protocol
The recovery period is critical for graft integration.
- Catheterization: A silicone Foley catheter remains in place for 14 to 21 days to provide a stent for the healing urethra.
- Mouth Care: Patients are instructed to use antiseptic mouthwash and maintain a soft diet for 7–10 days post-operatively.
- Activity Restrictions: No heavy lifting or strenuous exercise for 4–6 weeks to prevent tension on the perineal wound.
- Follow-up: RUG is performed at 3 weeks. If the contrast study shows no extravasation, the catheter is removed.
6. Risks, Side Effects, and Complications
While BMGU has a high success rate (80–90%), patients must be aware of potential risks.
Urethral Complications:
- Stricture Recurrence: Usually occurs within the first 12–24 months.
- Urethrocutaneous Fistula: Rare, but requires secondary repair.
- Post-void Dribbling: Common in bulbous urethroplasty due to the loss of the bulbospongiosus muscle function.
- Infection: Managed with targeted antibiotic therapy.
Donor Site Complications:
- Pain: Managed with NSAIDs and topical anesthetic gels.
- Nerve Damage: Temporary numbness of the lower lip or cheek.
- Tightness: Rare, if the harvest area is too large.
7. Alternative Treatments
| Procedure | Best For | Limitation |
|---|---|---|
| DVIU (Internal Urethrotomy) | Short, primary strictures | High recurrence rate |
| Dilation | Temporary relief | Not curative |
| Excision & Primary Anastomosis | Short (<1.5cm) bulbous strictures | Requires tension-free closure |
| Stenting | Medically unfit patients | High risk of encrustation |
8. Frequently Asked Questions (FAQ)
Q1: How long does the procedure take?
Typically 2 to 4 hours, depending on the length of the stricture and the complexity of the reconstruction.
Q2: Is the buccal mucosa donor site painful?
Most patients report mild to moderate discomfort for 3–5 days. It is easily managed with oral analgesics.
Q3: Will my mouth look different after the graft?
No. The donor site is internal, and the mucosal tissue heals rapidly with minimal scarring.
Q4: What is the success rate of BMGU?
Success rates range from 80% to 92%, making it one of the most reliable reconstructive procedures in urology.
Q5: Can I eat normally after the surgery?
You will need a soft, non-acidic diet for about one week to allow the donor site to heal properly.
Q6: What if the stricture recurs?
Recurrence is evaluated via cystoscopy. Options include minor endoscopic revision or secondary urethroplasty.
Q7: How long must I keep the catheter in?
Standard practice is 2–3 weeks to ensure the graft has fully integrated with the urethral tissue.
Q8: Does this affect sexual function?
Generally, no. However, some patients may experience temporary perineal sensitivity.
Q9: Is BMGU suitable for everyone?
It is not suitable for patients with insufficient buccal mucosa or those with severe systemic health issues that preclude major surgery.
Q10: Why is buccal mucosa better than skin grafts?
Buccal mucosa is more robust, has a higher survival rate in a wet environment, and does not grow hair, which can cause stone formation in the urethra.
9. Conclusion
Buccal Mucosal Graft Urethroplasty represents the pinnacle of urethral reconstructive surgery. By leveraging the biological advantages of oral mucosa, surgeons can provide a permanent solution to debilitating urethral stricture disease. Success relies heavily on meticulous surgical technique, proper graft "quilting," and strict adherence to post-operative catheter protocols. As surgical techniques continue to evolve, the integration of robotic-assisted approaches for BMGU is expected to further refine outcomes, potentially reducing morbidity and recovery times.
For clinicians, the key to optimal patient outcomes remains patient selection and long-term surveillance. With appropriate management, BMGU transforms the quality of life for patients suffering from chronic, obstructive uropathy.
Disclaimer: This guide is for educational purposes for healthcare professionals and does not replace institutional protocols or individual clinical judgment. Always refer to the latest evidence-based guidelines from the AUA or EAU.